Median Technologies SA (ALMDT.PA)

15.52 -0.36 (-2.27%) At close: 5:35PM CET

Median Technologies SA

Les Deux Arcs B
1800 route des CrEtes
Valbonne 06560
France

http://www.mediantechnologies.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 141

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Fredrik Brag	Founder, GM, CEO & Director	498k	N/A	N/A
Mr. Jean-Christophe Montigny	Chief Financial Officer	N/A	N/A	1965
Marjorie Kooman	VP and Head of Investor & Media Relations	N/A	N/A	N/A
Emmanuelle Leygues	Head of Corp. & Marketing Communications	N/A	N/A	N/A
Ms. Sophie Campagno	Chief of HR & Corp. Services	N/A	N/A	N/A
Mr. Ciaran Mark Cooper	Head of Bus. Devel., Clinical Trials Imaging - North America	N/A	N/A	N/A
Mr. Takashi Hayashi	Managing Director of Japan	N/A	N/A	N/A
Bill Broderick	VP and Global Head of Bus. Support & Market Services	N/A	N/A	N/A
Dr. Yan Liu	Chief Medical Officer	N/A	N/A	N/A
Mr. Nicolas Dano	Chief Operating Officer of iCRO Bus. Unit	N/A	N/A	N/A

Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiopsy (Imaging BIOmarker Phenotyping System), a phenomics imaging platform empower translational research with AI powered Biomarker identification tools and inform clinical decisions using CT scan similarity search for patient profiling services; and iSee for image analysis and management in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies. Median Technologies SA has a research collaboration agreement with the University of California San Diego to conduct a study for its proprietary imaging platform iBiopsy validation. The company was founded in 2002 and is based in Valbonne, France.

Corporate governance

Median Technologies SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.